GNOMvsARKGETF Comparison
VS
Global X Genomics & Biotechnology ETF - USD (GNOM) and ARK Genomic Revolution ETF (ARKG) belong to the same industry segment: BioTech & Genomics. Both ETFs have the same top 3 sector exposures: and Health Care. GNOM is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.75% for ARKG. GNOM is down -2.73% year-to-date (YTD) with -$602K in YTD flows. ARKG performs worse with -7.2% YTD performance, and -$34M in YTD flows. Run a side-by-side ETF comparison of GNOM and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
GNOM vs ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 04/02/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNOM ARKG | -5.92%-9.43% | -3.18%-9.70% | -2.73%-7.20% | +40.41%+34.19% | -8.52%-9.05% | -51.20%-69.51% |
| Flows | GNOM ARKG | +$1M-$124M | -$602K-$34M | -$602K-$34M | -$14M-$132M | -$118M-$639M | +$14M-$2.91B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNOM ARKG | +28.54%+44.26% | +30.12%+44.73% | +28.76%+42.50% | +33.30%+45.25% |
| Max drawdown | GNOM ARKG | -18.16%-27.52% | -18.16%-27.52% | -46.50%-51.98% | -72.17%-80.16% |
| Max drawdown duration | GNOM ARKG | 70d69d | 70d69d | 1053d987d | 1736d1737d |
Trading data
GNOM | ARKG | |
Last sale 4/2/2026 at 1:30 PM | $44.19 | $27.36 |
| Previous close 04/02/2026 | $44.19 | $27.09 |
| Consolidated volume 04/02/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of March 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexGNOM | ARKG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 4/2/2026 at 1:30 PM
Live
Closed
GNOM | ARKG | |
|---|---|---|
| Last price | $44.19 | $27.36 |
| 1D performance | +0.00% | +1.00% |
| AuM | $49.82 M | $1.06 B |
| E/R | 0.5% | 0.75% |
Characteristics
GNOM | ARKG | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Global X | Ark Investment |
| Benchmark | Solactive Genomics Index | - |
| N° of holdings | 46 | 29 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 5, 2019 | April 2, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
GNOM
USA
86.7%
Other
13.3%
ARKG
USA
70.98%
Switzerland
9.96%
Other
19.06%
Sectors
GNOM
Health Care
88%
Other
12%
ARKG
Health Care
79.1%
Other
20.9%
Diversification
GNOM
Total weight of top 15 holdings out of 15
64.03%
ARKG
Total weight of top 15 holdings out of 15
62.88%
Top 15 holdings
Data as of February 28, 2026
GNOM
MODERNA INC
7.58%
US74006W2070
6.30%
ARROWHEAD PHARMACEUTICALS INC
5.70%
GUARDANT HEALTH INC
4.91%
ILLUMINA
4.86%
BIOMARIN PHARMACEUTICAL
4.27%
VERTEX PHARMACEUTICALS
4.17%
NATERA
4.06%
BIONTECH SE ADR
3.81%
AVIDITY BIOSCIENCES
3.79%
CRISPR THERAPEUTICS
3.58%
BIO-TECHNE CORP
3.38%
BRISTOL-MYERS SQUIBB
2.60%
VERACYTE INC/D
2.53%
ALNYLAM PHARMACEUTICALS
2.49%
ARKG
CRISPR THERAPEUTICS
9.96%
10X GENOMICS INC
6.07%
PERSONALIS INC
5.93%
BEAM THERAPEUTICS
5.12%
ILLUMINA
4.28%
NATERA
4.11%
GUARDANT HEALTH INC
3.94%
RECURSION PHARMACEUTICALS
3.73%
CAREDX INC/D
3.40%
INTELLIA THERAPEUTICS INC
3.35%
VERACYTE INC/D
3.21%
ADAPTIVE BIOTECHNOLOGIES
2.76%
ABSCI
2.64%
IONIS PHARMACEUTICALS INC
2.34%
SCHRODINGER
2.04%
Frequently asked questions about GNOM and ARKG
How have the GNOM and ARKG ETFs performed in 2026?
As of April 2, 2026, GNOM is down -2.73% year-to-date (YTD), while ARKG has lost -7.2%. That puts GNOM better performer ahead so far this year.
Which ETF is attracting more investor money: GNOM or ARKG?
Year-to-date, the GNOM ETF saw -$602K in flows, compared to -$34M for ARKG.
Which ETF is more volatile: GNOM or ARKG?
Over the past year, GNOM had a volatility of 30.12%, while ARKG experienced 44.73%.
Which ETF is bigger: GNOM or ARKG?
As of April 2, 2026, GNOM holds $49.82 M in assets under management (AUM), while ARKG manages $1.06 B.
What sectors do the GNOM and ARKG ETFs invest in?
GNOM leans toward sectors like Health Care. Meanwhile, ARKG focuses on Health Care.
What are the top holdings of the GNOM ETF and ARKG ETF?
GNOM top holdings include MODERNA INC, US74006W2070 and ARROWHEAD PHARMACEUTICALS INC. ARKG holds in its top three: CRISPR THERAPEUTICS, 10X GENOMICS INC and PERSONALIS INC.
Which ETF is more diversified: GNOM or ARKG?
GNOM holds 48 securities with 64.03% of its assets in the top 15. ARKG has 29 securities and a top 15 weight of 62.88%.
Advertisement
Latest news about GNOM & ARKG
Advertisement
